BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 31175896)

  • 1. Systematic review of targeted extracellular vesicles for drug delivery - Considerations on methodological and biological heterogeneity.
    Gudbergsson JM; Jønsson K; Simonsen JB; Johnsen KB
    J Control Release; 2019 Jul; 306():108-120. PubMed ID: 31175896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous cancer cell-derived extracellular vesicles as drug-delivery systems: a systematic review of preclinical and clinical findings and translational implications.
    Li YJ; Wu JY; Hu XB; Wang JM; Xiang DX
    Nanomedicine (Lond); 2019 Feb; 14(4):493-509. PubMed ID: 30694095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the use of liposome controls in studies investigating the clinical potential of extracellular vesicle-based drug delivery systems - A commentary.
    Johnsen KB; Gudbergsson JM; Duroux M; Moos T; Andresen TL; Simonsen JB
    J Control Release; 2018 Jan; 269():10-14. PubMed ID: 29126999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Affecting Extracellular Vesicles Based Drug Delivery Systems.
    Gaurav I; Thakur A; Iyaswamy A; Wang X; Chen X; Yang Z
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems.
    Piffoux M; Silva AKA; Wilhelm C; Gazeau F; Tareste D
    ACS Nano; 2018 Jul; 12(7):6830-6842. PubMed ID: 29975503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems.
    Maeki M; Kimura N; Sato Y; Harashima H; Tokeshi M
    Adv Drug Deliv Rev; 2018 Mar; 128():84-100. PubMed ID: 29567396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of individual extracellular vesicles by imaging flow cytometry.
    Tertel T; Görgens A; Giebel B
    Methods Enzymol; 2020; 645():55-78. PubMed ID: 33565978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time.
    Kooijmans SAA; Fliervoet LAL; van der Meel R; Fens MHAM; Heijnen HFG; van Bergen En Henegouwen PMP; Vader P; Schiffelers RM
    J Control Release; 2016 Feb; 224():77-85. PubMed ID: 26773767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes and Extracellular Vesicles as Drug Delivery Systems: A Comparison of Composition, Pharmacokinetics, and Functionalization.
    van der Koog L; Gandek TB; Nagelkerke A
    Adv Healthc Mater; 2022 Mar; 11(5):e2100639. PubMed ID: 34165909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular Vesicles as Drug Delivery Systems - Methods of Production and Potential Therapeutic Applications.
    Surman M; Drożdż A; Stępień E; Przybyło M
    Curr Pharm Des; 2019; 25(2):132-154. PubMed ID: 30848183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of Extracellular Vesicles Loaded with Therapeutic Cargo.
    Lamichhane TN; Jay SM
    Methods Mol Biol; 2018; 1831():37-47. PubMed ID: 30051423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are extracellular vesicles new hope in clinical drug delivery for neurological disorders?
    Muhammad SA
    Neurochem Int; 2021 Mar; 144():104955. PubMed ID: 33412233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
    Meng W; He C; Hao Y; Wang L; Li L; Zhu G
    Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Significance and Therapeutic Potential of Extracellular vesicles.
    Luo R; Liu M; Tan T; Yang Q; Wang Y; Men L; Zhao L; Zhang H; Wang S; Xie T; Tian Q
    Int J Biol Sci; 2021; 17(10):2476-2486. PubMed ID: 34326688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategic design of extracellular vesicle drug delivery systems.
    Armstrong JPK; Stevens MM
    Adv Drug Deliv Rev; 2018 May; 130():12-16. PubMed ID: 29959959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Inflammatory Vasculature by Extracellular Vesicles.
    Wang S; Dong X; Gao J; Wang Z
    AAPS J; 2018 Feb; 20(2):37. PubMed ID: 29484558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Vesicles as Biological Shuttles for Targeted Therapies.
    Raimondo S; Giavaresi G; Lorico A; Alessandro R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.